Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Reason to Buy Bluebird Bio, and 1 Reason to Sell

TheMotleyFool

0 0

1 Reason to Buy Bluebird Bio, and 1 Reason to Sell: https://g.foolcdn.com/editorial/images/693282/patient-sitting-on-hospital-bed.jpg

As biotech investors know all too well, companies in this industry can be highly volatile. Substantial price swings over short periods aren't that rare, particularly for clinical-stage biotechs. That means many of these stocks boast significant upside potential, but picking the wrong drugmaker could leave investors with worthless shares.

Let's consider one biotech that could be on the verge of a massive upswing despite its struggles over the past few years: Bluebird Bio (NASDAQ: BLUE). Is this gene-editing specialist worth your hard-earned money? Here are two arguments for each side of that question.